V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007119 | 220002774 | 1.63 | 79 | Palliative (P) | 2016-10-08 | 2016-10-16 | AML16 Low Dose Cytarabine | N | N | 220031734 | AML16 TRIAL |
| 220007120 | 220011585 | null | 84.2 | Neo-adjuvant (N) | 2013-06-08 | 2013-06-12 | AML 18 TRIAL | Y | N | 220031735 | AML18 TRIAL |
| 220007121 | 220002775 | 0 | null | Palliative (P) | 2013-03-29 | 2013-04-18 | CARBOPLATIN + PACLITAXEL | 02 | N | 220031736 | CARBOPLATIN + PACLITAXEL |
| 220007122 | 220002776 | null | 0 | Palliative (P) | 2013-01-17 | 2013-02-25 | AML16 DA 3+10 | N | N | 220031741 | AML16 TRIAL |
| 220007123 | 220002776 | 1.63 | 126.1 | Palliative (P) | 2013-11-22 | 2013-12-15 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220031741 | CISPLATIN + GEMCITABINE |
| 220007127 | 220002778 | 0 | 95.1 | Palliative (P) | 2014-12-05 | 2014-12-05 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220031748 | IDARUBICIN + TRETINOIN |
| 220007128 | 220011588 | 1.6 | 82.9 | Palliative (P) | 2013-10-21 | 2013-10-27 | Dasatinib | 02 | N | 220031749 | DASATINIB |
| 220007129 | 220016235 | 1.67 | 101.7 | Palliative (P) | 2016-09-07 | 2016-09-07 | GemCarbo Days 1+8 | N | N | 220031751 | GEMCARBO |
| 220007130 | 220016235 | 1.59 | null | Palliative (P) | 2014-01-14 | 2014-01-14 | Cisplatin+Gemcitabine (gallbladder) | N | N | 220031751 | CISPLATIN + GEMCITABINE |
| 220007131 | 220016235 | 1.64 | 0 | null | 2017-11-07 | 2017-11-07 | CISPLATIN + GEMCITABINE | 02 | N | 220031751 | CISPLATIN + GEMCITABINE |
| 220007132 | 220016235 | 0 | 87.7 | Curative (C) | 2017-03-17 | 2017-03-17 | IDARUBICIN + TRETINOIN | N | N | 220031751 | IDARUBICIN + TRETINOIN |
| 220007133 | 220002779 | 1.8 | 81.6 | Curative (C) | 2016-04-01 | 2016-04-01 | IDARUBICIN + TRETINOIN | N | N | 220031759 | IDARUBICIN + TRETINOIN |
| 220007134 | 220002780 | null | null | Palliative (P) | null | 2017-12-11 | CARBOPLATIN + PACLITAXEL | N | N | 220031764 | CARBOPLATIN + PACLITAXEL |
| 220007135 | 220002780 | 1.59 | 55.7 | Curative (C) | 2015-05-14 | 2015-05-17 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220031764 | IDARUBICIN + TRETINOIN |
| 220007136 | 220002780 | null | 76.2 | Palliative (P) | 2016-03-07 | 2016-03-12 | GEMCARBO | 02 | N | 220031764 | GEMCARBO |
| 220007137 | 220002780 | 1.7 | null | Palliative (P) | 2015-02-12 | 2015-02-22 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220031764 | CARBOPLATIN + PACLITAXEL |
| 220007138 | 220020405 | 1.69 | null | Curative (C) | 2014-06-30 | 2014-07-13 | AML16 DA 3+10 | N | N | 220031771 | AML16 TRIAL |
| 220007141 | 220002782 | 1.49 | null | Curative (C) | null | 2016-04-13 | AML 18 TRIAL | Y | N | 220031780 | AML18 TRIAL |
| 220007142 | 220002783 | 1.79 | 100.7 | Palliative (P) | 2013-12-03 | 2013-12-05 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031784 | CARBOPLATIN + PACLITAXEL |
| 220007143 | 220002784 | 1.59 | 80 | Curative (C) | 2017-04-18 | 2017-05-10 | IDARUBICIN + TRETINOIN | 02 | N | 220031787 | IDARUBICIN + TRETINOIN |
| 220007144 | 220002784 | 1.57 | 66.5 | null | 2017-12-09 | 2017-12-20 | GemCarbo Days 1+8 | 02 | null | 220031787 | GEMCARBO |
| 220007145 | 220002785 | 1.69 | 81.8 | Curative (C) | 2014-08-17 | 2014-08-17 | AML 18 Pilot Trial | N | N | 220031790 | PILOT TRIAL |
| 220007146 | 220002786 | 1.76 | 83.1 | null | 2013-04-06 | 2013-04-06 | CISPLATIN + GEMCITABINE | N | N | 220031792 | CISPLATIN + GEMCITABINE |
| 220007147 | 220002786 | 1.68 | 67.3 | Curative (C) | 2014-01-25 | 2014-01-27 | Idarubicin+Tretinoin Spanish Crse2 | Y | null | 220031792 | IDARUBICIN + TRETINOIN |
| 220007148 | 220002787 | 1.62 | 85.1 | Palliative (P) | 2016-03-01 | 2016-04-02 | AML16 DA 3+10 | N | N | 220031796 | AML16 TRIAL |
| 220007149 | 220002788 | 1.55 | 70.8 | Palliative (P) | null | 2018-01-15 | CARBOPLATIN + GEMCITABINE | N | N | 220031797 | GEMCARBO |
| 220007150 | 220002788 | null | 0 | Palliative (P) | 2013-10-18 | 2013-11-01 | Carboplatin + Paclitaxel (3 weekly) | null | N | 220031797 | CARBOPLATIN + PACLITAXEL |
| 220007151 | 220002788 | 1.82 | null | null | 2014-04-06 | 2014-04-14 | CISPLATIN + GEMCITABINE | null | N | 220031797 | CISPLATIN + GEMCITABINE |
| 220007152 | 220002788 | 1.73 | null | Palliative (P) | 2018-01-15 | 2018-01-22 | CISPLATIN + GEMCITABINE | 02 | N | 220031797 | CISPLATIN + GEMCITABINE |
| 220007153 | 220020406 | 1.62 | 47.2 | Curative (C) | null | 2013-10-04 | AML 18 TRIAL | 1 | N | 220031805 | AML18 TRIAL |
| 220007154 | 220020406 | 1.54 | 80 | Curative (C) | 2015-06-02 | 2015-06-09 | Carboplatin 21day + Paclitaxel 7day | N | N | 220031805 | CARBOPLATIN + PACLITAXEL |
| 220007155 | 220020406 | 1.71 | null | Palliative (P) | 2016-09-08 | 2016-09-10 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220031805 | CARBOPLATIN + PACLITAXEL |
| 220007156 | 220002789 | 1.56 | 57 | Palliative (P) | 2018-06-17 | 2018-06-28 | Dasatinib | 1 | N | 220031809 | DASATINIB |
| 220007157 | 220002790 | 1.54 | 58.4 | Curative (C) | 2016-05-07 | 2016-05-12 | AML 18 Pilot Trial | Y | N | 220031811 | PILOT TRIAL |
| 220007159 | 220002792 | 1.79 | 71 | Curative (C) | 2017-10-20 | 2017-10-26 | AML16 DA 3+10 | 02 | N | 220031813 | AML16 TRIAL |
| 220007163 | 220002795 | 1.67 | 73.3 | Curative (C) | null | 2016-01-16 | AML 18 TRIAL | 1 | N | 220031820 | AML18 TRIAL |
| 220007164 | 220002795 | 1.7 | 71.4 | Curative (C) | 2013-11-13 | 2013-11-16 | AML18 PILOT TRIAL | Y | N | 220031820 | PILOT TRIAL |
| 220007165 | 220002795 | 1.7 | 47.2 | Disease modification (D) | null | 2013-11-03 | IDARUBICIN + TRETINOIN | N | Y | 220031820 | IDARUBICIN + TRETINOIN |
| 220007166 | 220002795 | 1.68 | 109 | Palliative (P) | 2014-08-23 | 2014-09-03 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 220031820 | CISPLATIN + GEMCITABINE |
| 220007167 | 220002795 | 1.52 | 84 | Curative (C) | 2013-09-10 | 2013-09-10 | AML18 PILOT TRIAL | Y | N | 220031820 | PILOT TRIAL |
| 220007168 | 220002796 | null | 76.1 | Curative (C) | null | 2017-10-09 | AML 18 TRIAL | 01 | N | 220031840 | AML18 TRIAL |
| 220007169 | 220002797 | 1.67 | null | Palliative (P) | 2015-01-11 | 2015-02-02 | GemCarbo Days 1+8 | null | N | 220031842 | GEMCARBO |
| 220007170 | 220002797 | null | null | Curative (C) | null | 2013-12-21 | AML 18 TRIAL | Y | Y | 220031842 | AML18 TRIAL |
| 220007171 | 220002798 | 1.55 | 78.8 | Palliative (P) | 2015-05-20 | 2015-05-20 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220031845 | IDARUBICIN + TRETINOIN |
| 220007172 | 220002799 | 1.85 | 0 | Curative (C) | 2017-11-27 | 2017-12-02 | AML18 PILOT TRIAL | Y | Y | 220031847 | PILOT TRIAL |
| 220007173 | 220002800 | null | 64.5 | Palliative (P) | 2013-02-14 | 2013-02-27 | GEMCARBO | N | null | 220031849 | GEMCARBO |
| 220007174 | 220002801 | null | 71.45 | Palliative (P) | 2014-10-04 | 2014-10-04 | Carboplatin + Paclitaxel (weekly) | N | N | 220031850 | CARBOPLATIN + PACLITAXEL |
| 220007175 | 220002802 | null | 73.4 | Palliative (P) | 2016-05-09 | 2016-05-10 | IDARUBICIN + TRETINOIN | N | null | 220031851 | IDARUBICIN + TRETINOIN |
| 220007176 | 220002803 | 1.8 | 93 | Palliative (P) | 2017-08-17 | 2017-08-17 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 220031857 | CISPLATIN + GEMCITABINE |
| 220007177 | 220002803 | 1.57 | 69 | Palliative (P) | 2015-02-22 | 2015-02-26 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220031857 | CARBOPLATIN + PACLITAXEL |